Skip to content
Aperio logo — company profile

Aperio

Founded 1999 United States Vista, United States 86 employees Debt Financing Total: $61.65M Biotechnology, Health Care +1

General Information

Company Name Aperio
Founded Year 1999
Location United States Vista, United States
Employees 86
Industries Biotechnology, Health Care, Pharmaceutical
Funding Stage Debt Financing
Social

BounceWatch is an independent company data service, not affiliated with Aperio. To contact Aperio, visit aperio.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Aperio compare?

A PDF of Aperio and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Aperio soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Aperio

Aperio, a biotechnology and healthcare startup based in the United States, was founded in 1999 and is headquartered in Vista, CA, approximately 35 miles north of San Diego. The company has developed technology to digitize and securely share glass slides, revolutionizing the practice of pathology in hospitals, reference labs, pharmaceutical, and research institutions globally. Aperio's ePathology Solutions, including the NETWORK and PRECISION tools, empower pathologists with advanced analytic capabilities, real-time viewing, and collaboration features. The company's web-based software platform ensures integration with existing systems for transparency, consistency, and efficiency in pathology operations. In its most recent funding round, Aperio secured a $5.82M debt financing investment on 09 August 2012. The company serves a crucial role in supporting patient care, personalized medicine, and research through its innovative solutions. For further details on clearance updates and specific product indications, interested parties can visit www.aperio.com. With its strong track record and innovative products, Aperio presents an exciting opportunity for potential investors in the biotechnology and healthcare sectors.

Business keywords: digital pathology, ePathology Solutions, pathology software, digital imaging, telepathology, pathology analytics, diagnostic imaging, research collaboration, precision medicine, medical diagnostics, healthcare efficiency, pathology operations

Funding Rounds & Investors (6)

View All
Funding Stage Amount Investors Lead Investors Date
Debt Financing $5.82M -
09 Aug 2012
Series C $20.00M 5
Advanced Technology Ventures, BlackRock +3
13 Mar 2008
Series C $10.60M 2
Advanced Technology Ventures, Galen Partners
30 May 2007
Venture Round $12.00M 2
Advanced Technology Ventures, Galen Partners
08 Dec 2005
Series B $10.00M 1
Goldman Sachs
02 Nov 2004
Series A $3.23M -
26 Mar 2002

Aperio Alternatives & Competitors

View All Alternatives
Aperio vs
Clarapath
Clarapath United States

Pioneering a future of precision in pathology with automated solutions that promise superior quality...

Series B
63 employees
Biotechnology, Health Care
Aperio vs
Atrys
Atrys Spain

Prevention and precision care for people

Post-IPO Equity
245 employees
Biotechnology, Health Care
Aperio vs

Pioneering AI-based cancer diagnostics in pathology

Series C
95 employees
AI, Analytics

FAQ About Aperio

For over a decade, Aperio has advanced the technology that enables glass slides to be digitized and securely shared with others. Aperio products are transforming the practice of pathology in hospitals, reference labs and pharmaceutical and research institutions around the world. From the moment glas...
Aperio was founded in 1999.
Aperio is headquartered in Vista, United States.
Aperio operates in Biotechnology, Health Care and Pharmaceutical. Its work centres on digital pathology, ePathology Solutions, pathology software and digital imaging.
Aperio has approximately 86 employees.
Aperio has completed 6 funding rounds, raising a total of $61.65M. The latest funding stage is Debt Financing.
Top alternatives and competitors to Aperio include Clarapath, Atrys, Ibex Medical Analytics, Imaginostics, Qritive. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Aperio and Clarapath are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Aperio, https://bouncewatch.com/company/aperio-1, updated 14 January 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout